Full Access
Mechanisms of human eosinophil survival and apoptosis
G. M. WALSH,
G. M. WALSH
Department of Respiratory Medicine, University of Leicester, School of Medicine, Glenfield Hospital, Leicester, UK
Search for more papers by this authorG. M. WALSH,
G. M. WALSH
Department of Respiratory Medicine, University of Leicester, School of Medicine, Glenfield Hospital, Leicester, UK
Search for more papers by this author
References
- 1 Wyllie AH, Kerr JFR, Currie AR. Cell death. The significance of apoptosis. Int Rev Cytol 1980; 68: 251–306.
- 2 Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397–400.
- 3 Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. New Engl J Med 1990; 323: 1033–5.
- 4 Gleich GJ. The eosinophil and bronchial asthma. J Allergy Clin Immunol 1990; 85: 422–36.
- 5 Bochner B, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1995; 94: 427–38.
- 6 Wardlaw AJ, Walsh GM, Symon FA. Mechanisms of eosinophil and basophil migration. Allergy 1994; 49: 797–807.
- 7 Simon H-U, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia Immunol Today 1995; 16: 53–5.
- 8 Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils; Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992; 148: 3543–9.
- 9 Beauvais F, Michel L, Dubertret L. Human eosinophils in culture undergo a striking and rapid shrinkage during apoptosis. Role of K+ channels. J Leuk Biol 1995; 57: 851–5.
- 10 Owen WF, Rothenburg ME, Silberstein DS et al. Regulation of human eosinophil viability, density and function by granulocyte/macrophage colony stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987; 166: 129–41.
- 11 Rothenberg ME, Petersen J, Stevens RL, Silberstein DS, McKenzie DT, Austin KF, Owen WF. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype used 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143: 2311–6.
- 12 Rothenberg ME, Owen WF, Silberstein DS et al. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81: 1986–92.
- 13 Her E, Frazer J, Austen KF, Owen WF. Eosinophil hemato-poietins antagonize the programme cell death of eosinophils. J Clin Invest 1991; 88: 1982–7.
- 14 Tai P-C, Sun L, Spry CFJ. Effects of IL-5, GM-CSF and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1992; 85: 312.
- 15 Yamaguchi Y, Sudo T, Ohata S, Tominaga K, Miura Y, Kasa T. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78: 2542–7.
- 16 Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501–7.
- 17 Ramis I, Finotto S, Dolovich J, Marshall J, Jordana M. Increased survival of nasal polyp eosinophils. Immunol Letters 1995; 45: 219–21.
- 18 Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994; 94: 1183–8.
- 19 Anwar ARE, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993; 177: 839–43.
- 20 Walsh GM, Symon FS, Wardlaw AJ. Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin Exp Allergy 1995; 25: 1128–35.
- 21 Tourkin A, Anderson T, LeRoy EC. Eosinophil adhesion and maturation is modulated by laminin. Cell Adhesion Communic 1993; 1: 161–76.
- 22 Cox G, Ohtoshi T, Vancheri C et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Resp Cell Mol Biol 1991; 4: 525–31.
- 23 Takanaski S, Nonaka R, Xing Z et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by peripheral human blood eosinophils. J Exp Med 1994; 180: 511–5.
- 24 Berridge MJ. Inositol triphoshate and calcium signalling. Nature 1993; 361: 315–25.
- 25 Hossain M, Okubo Y, Sekiguchi M. Effects of various drugs (staurosporin, herbimycin A, ketotifen, theophyline, FK506 and cyclosporin A) on eosinophil viability. Jap J Allergology 1994; 43: 711–7.
- 26 Yousefi S, Green DR, Blaser K, Simon H-U. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci 1994; 91: 10868–72.
- 27 Van der Bruggen T, Kok PTM, Raaijmakers JAM, Verhoeven AJ, Kessels RGC, Lammers JWJ, Koenderman L. Cytokine priming of the respiratory burst in human eosinophils is Ca2+ independent and accompanied by induction of tyrosine kinase activity. J Leuk Biol 1993; 53: 347–53.
- 28 Pazdrak PK, Stafford S, Alam R. The activation of the Jak-STAT signalling pathway of IL-5 in eosinophils. J Immunol 1995; 155: 397–402.
- 29 Van der Bruggen T, Caldenhove TE, Kanters D et al. Interleukin 5 signaling in human eosinophils involves the Jak-2 tyrosine kinase and Stat-1al. Blood 1995; 85: 1442.
- 30 Bates ME, Betrics PJ, Busse WW. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 1996; 156: 711–8.
- 31 Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R. The intracellular signal transduction mechanisms of interleukin-5 in eosinophils: the involvement of Lyn tyrosine kinase and the ras-raf 1-MEK-MAP kinase pathway. J Exp Med 1995; 181: 1827–34.
- 32 Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon H-U. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996; 183: 1407–14.
- 33 Alam R, Forsythe P, Stafford S, Fukada Y. Transforming growth factor-β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994; 179: 1041–5.
- 34 Ohno I, Lea RG, Flanders KC et al. Eosinophils in chronically inflammed human upper airway tissues express transforming growth factor-β1 gene (TGF-β1). J Clin Invest 1992; 89: 1662–8.
- 35 Pazdrak K, Justement L, Alum R. Mechanism of inhibition of eosinophil activation by transforming growth factor-β. J Immunol 1995; 155: 4454–8.
- 36 Schleimer RP. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Resp Dis 1990; 141: 559–69.
- 37 Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991; 147: 3490–5.
- 38 Lamas AM, Leon OG, Schleimer RP. Glucocorticoids inhibit eosinophil responses of granulocyte-macrophage colony-stimulating factor. J Immunol 1991; 147: 254–9.
- 39 Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156: 4422–8.
- 40 Kawabori S, Soda K, Perdue MH, Bienenstock J. The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone. Lab Invest 1991; 64: 224–33.
- 41 Wooley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Wooley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 237–43.
- 42 Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449–55.
- 43 Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437–43.
- 44 Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M. Fas-mediated apoptosis in cultured human eosinophils. Blood 1996; 87: 2822–30.
- 45 Tsuyuki S, Bertrand C, Erard F, Trifilieff A, Tsuyuki J, Wesp M, Andersen GP, Coyle AJ. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995; 96: 2924–31.
- 46 Eischen C, Dick CJ, Leibson PJ. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 1994; 153: 1947–54.
- 47 Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Imm Today 1994; 15: 479–83.
- 48 Hartnell A, Robinson DS, Kay AB, Warlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunol 1993; 80: 281–6.
- 49 Nishikawa K, Morii T, Ako H, Hamada K, Saito S, Narita N. In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils. J Allergy Clin Immunol 1992; 90: 169–74.
- 50 Walsh GM, Williamson ML, Symon FA, Wilars GB, Wardlaw AJ. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with GM-CSF. Blood 1996; 87: 2815–21.
- 51 Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 338: 720–2.
- 52 Savill JS, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1992; 14: 131–6.
- 53 Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leuk Biol 1992; 52: 269–73.
- 54 Stern M, Savill J, Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Am J Path 1996; 149: 911–21.
- 55 Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991; 338: 720–2.
- 56 Cox G, Crossley, Xing Z. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol 1995; 12: 232–7.
- 57 Bennet MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995; 77: 1136–42.
- 58 Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the intiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545–56.
- 59 Homburg CHE, de Haas M, von dem Borne AEG et al. Human neutrophils lose their surface FCgmRIII and acquire annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532–40.
- 60 Lagasse E, Weissman IL. Bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 1994; 179: 1047–52.
- 61 Ohta K, Iwai K, Kasahara Y et al. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-x and Mcl-1 in human peripheral blood and lymphoid tissues. Int Immunol 1995; 7: 1817–25.
- 62 Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996; 10: 587–97.
Citing Literature
